Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Pitt study shows doctors use different body language depending on patients' race

Pitt study shows doctors use different body language depending on patients' race

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Research opens door to validation studies in multiple tumor types of liquid biopsy

Research opens door to validation studies in multiple tumor types of liquid biopsy

Family members of CUP patients at higher risk of developing CUP themselves

Family members of CUP patients at higher risk of developing CUP themselves

Nutritionist offers myriad methods to help people eat during cancer treatment

Nutritionist offers myriad methods to help people eat during cancer treatment

ICGC article lays foundation for the coming era of cancer genomic research

ICGC article lays foundation for the coming era of cancer genomic research

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

VolitionRx's NuQ blood tests accurately detect more than 90% of lung cancer cases

VolitionRx's NuQ blood tests accurately detect more than 90% of lung cancer cases

Johns Hopkins scientists use gene-based tests to distinguish precancerous cysts from harmless cysts

Johns Hopkins scientists use gene-based tests to distinguish precancerous cysts from harmless cysts

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

New antenna-like device makes breast cancer surgery easier for surgeons

New antenna-like device makes breast cancer surgery easier for surgeons

MD Anderson study reveals why chemotherapy drugs not effective for many pancreatic cancer patients

MD Anderson study reveals why chemotherapy drugs not effective for many pancreatic cancer patients

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

CA 19-9 tumor marker test can help predict early-stage pancreatic cancer patients

CA 19-9 tumor marker test can help predict early-stage pancreatic cancer patients

New clinical trial uses aggressive treatment method for patients with pancreas cancer

New clinical trial uses aggressive treatment method for patients with pancreas cancer

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Specialized type of immunotherapy can boost survival from pancreatic cancer

Specialized type of immunotherapy can boost survival from pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.